Evaluation by HR-pQCT of Bone Microarchitecture Changes in Patients With Rheumatoid Arthritis Under Anti-TNF Therapy.

Trial Profile

Evaluation by HR-pQCT of Bone Microarchitecture Changes in Patients With Rheumatoid Arthritis Under Anti-TNF Therapy.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 24 Aug 2015

At a glance

  • Drugs Adalimumab (Primary) ; Etanercept (Primary) ; Infliximab (Primary)
  • Indications Polyarthritis; Rheumatoid arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top